| Literature DB >> 29114443 |
Alicja Mikolajczyk1, Natalia Sizochenko1,2, Ewa Mulkiewicz3, Anna Malankowska4, Michal Nischk4, Przemyslaw Jurczak5, Seishiro Hirano6, Grzegorz Nowaczyk7, Adriana Zaleska-Medynska4, Jerzy Leszczynski2, Agnieszka Gajewicz1, Tomasz Puzyn1.
Abstract
Titania-supported palladium, gold and bimetallic nanoparticles (second-generation nanoparticles) demonstrate promising photocatalytic properties. However, due to unusual reactivity, second-generation nanoparticles can be hazardous for living organisms. Considering the ever-growing number of new types of nanoparticles that can potentially contaminate the environment, a determination of their toxicity is extremely important. The main aim of presented study was to investigate the cytotoxic effect of surface modified TiO2-based nanoparticles, to model their quantitative nanostructure-toxicity relationships and to reveal the toxicity mechanism. In this context, toxicity tests for surface-modified TiO2-based nanoparticles were performed in vitro, using Gram-negative bacteria Escherichia coli and Chinese hamster ovary (CHO-K1) cells. The obtained cytotoxicity data were analyzed by means of computational methods (quantitative structure-activity relationships, QSAR approach). Based on a combined experimental and computational approach, predictive models were developed, and relationships between cytotoxicity, size, and specific surface area (Brunauer-Emmett-Teller surface, BET) of nanoparticles were discussed.Entities:
Keywords: Au/Pd–TiO2 photocatalyst; bimetallic nanoparticles; nano-QSAR; nanotoxicity; second-generation nanoparticles
Year: 2017 PMID: 29114443 PMCID: PMC5669235 DOI: 10.3762/bjnano.8.216
Source DB: PubMed Journal: Beilstein J Nanotechnol ISSN: 2190-4286 Impact factor: 3.649
Cytotoxicity and antimicrobial activity (MIC and microorganism growth inhibition zone) of TiO2 modified with Pd and/or Au nanoparticles.
| sample label | cytotoxicity EC50 (µg/mL) | antimicrobial activity | |
| MIC (µg/mL) | zone of inhibition diameter (mm)a | ||
| pure TiO2 | >300 | >500 | 6 |
| 0.1Au | 187.50 ± 0.43 | >500 | 6 |
| 0.25Au | 118.39 ± 2.19 | >500 | 9 |
| 1.25Au | 156.80 ± 0.42 | >500 | 9 |
| 0.1Pd | 164.18 ± 1.75 | >500 | 6 |
| 0.25Pd | 186.35 ± 1.73 | >500 | 6 |
| 0.5Pd | 204.02 ± 1.96 | >500 | 6 |
| 0.5Pd_1.25Au | 275.63 ± 3.13 | >500 | 6 |
| 0.1Pd_0.1Au | 165.96 ± 0.76 | >500 | 6 |
| 0.1Pd_0.25Au | 158.00 ± 0.92 | >500 | 6 |
| 0.1Pd_0.5Au | 195.73 ± 1.82 | >500 | 7 |
| 0.1Pd_1.25Au | 155.35 ± 2.38 | >500 | 7 |
| 0.5Pd_0.1Au | 141.91 ±1.73 | >500 | 6 |
| 0.5Pd_0.25Au | 175.12 ± 1.91 | >500 | 6 |
| 0.5Pd_0.5Au | 162.68 ± 2.29 | >500 | 7 |
| 0.25Pd_0.25Au | 134.28 ± 1.35 | >500 | 6 |
| 0.25Pd_0.5Au | 241.73 ± 3.07 | >500 | 6 |
| 0.25Pd_1.25Au | 220.80 ± 0.51 | >500 | 6 |
aA value of 6 equals the diameter of the paper disc, i.e., no inhibition occurred.
Figure 1The effect of the amount and type of metal precursor on the structure of the nanoparticles.
Figure 2Cytotoxicity of TiO2 modified with Pd and/or Au nanoparticles (NA: not available, these combinations were not investigated).
Summary data of developed descriptors.
| sample | type of NPa | BET surface area (m2/g) | sizemin of NPs (nm) | sizemax of NPs (nm) |
| Pure TiO2 | — | 154 ± 5 | 0 | 0 |
| 0.1Au | p | 168 ± 5 | 8 | 31 |
| 0.25Au | p | 139 ± 5 | 12 | 63 |
| 1.25Au | p | 140 ± 5 | 12 | 129 |
| 0.1Pd | p | 154 ± 5 | 4 | 4.5 |
| 0.25Pd | p | 182 ± 5 | 4 | 11 |
| 0.5Pd | p | 139 ± 5 | 3 | 12 |
| 0.5Pd_1.25Au | a | 139 ± 5 | 8 | 45 |
| 0.1Pd_0.1Au | cs | 156 ± 5 | 6 | 25 |
| 0.1Pd_0.25Au | a | 157 ± 5 | 63 | 140 |
| 0.1Pd_0.5Au | a | 148 ± 5 | 54 | 200 |
| 0.1Pd_1.25Au | a | 179 ± 5 | 5 | 17 |
| 0.5Pd_0.1Au | cs | 136 ± 5 | 15 | 35 |
| 0.5Pd_0.25Au | cs | 164 ± 5 | 19 | 40 |
| 0.5Pd_0.5Au | cs | 153 ± 5 | 8 | 80 |
| 0.25Pd_0.25Au | cs | 159 ± 5 | 17 | 170 |
| 0.25Pd_0.5Au | a | 158 ± 5 | 7 | 70 |
| 0.25Pd_1.25Au | cs | 145 ± 5 | 16 | 68 |
ap: pure NPs; a: alloy NPs; cs: core–shell.
Observed and predicted values for cytotoxicity of TiO2-based NPs.
| sample | status | observed cytotoxicity | predicted cytotoxicity | errors associated with predictions (µg/mL) |
| 1.25Au | training (bagging) | 156.80 | 162.38 (165.33) | 5.58 |
| 0.25Pd | training | 186.35 | 187.03 | 0.68 |
| 0.1Pd_0.1Au | training (bagging) | 165.96 | 169.12 (159.26) | 3.16 |
| 0.25Pd_1.25Au | training | 162.68 | 169.91 | 7.23 |
| 0.5Pd_1.25Au | training (bagging) | 275.63 | 264.60 (197.37) | 11.03 |
| 0.1Pd_1.25Au | training | 155.35 | 143.02 | 12.33 |
| 0.25Au | training | 118.39 | 126.65 | 8.26 |
| 0.1Pd_0.5Au | training (bagging) | 195.73 | 199.78 (171.02) | 4.05 |
| 0.25Pd_0.25Au | training (bagging) | 141.91 | 142.69 (156.06) | 0.78 |
| 0.1Pd | training | 164.18 | 163.35 | 0.83 |
| 0.5Pd_0.25Au | training | 241.73 | 224.70 | 17.03 |
| 0.5Pd_0.1Au | training | 134.28 | 150.21 | 15.93 |
| 0.25Pd_0.5Au | test | 175.12 | 170.42 | 4.7 |
| 0.1Au | test | 187.50 | 180.69 | 6.81 |
| 0.5Pd_0.5Au | test | 220.80 | 210.40 | 10.4 |
| 0.1Pd_0.25Au | test | 158.00 | 150.18 | 7.82 |
| 0.5Pd | test | 204.02 | 193.24 | 10.78 |
Figure 3Plot of experimentally determined (observed) vs predicted values of cytotoxicity based on developed nano-QSAR model.
Figure 4Y-randomization test.
Correlations value for each type of equation.
| type of NPs | Equation | equation type | ||
| linear | second-order polynomial | third-order polynomial | ||
| pure | 1 | 0.34 | 0.46 | 0.90 |
| alloy | 2 | 0.41 | 0.76 | 1.00 |
| core-shell | 3 | 0.09 | 0.63 | 1.00 |
Figure 5The graphical representation of goodness-of-fit and types of dependencies for the developed models.